Nebius Group (NBIS) Just Soared 34% on AI Infra Demand. Here's What to Expect This Week
Nebius Group NV (NASDAQ:NBIS) saw its share price jump by 34.14 percent on Wednesday to finish at $259.20 apiece, after reporting a more-than-fivefold growth in revenues, which signaled that the surging...
Hedge Funds
News & Analysis
Top Fund Managers
Best Performing Funds
Featured Content
Insider Trading
News & Analysis
Latest Insider Purchases
Stetz bought 500,000 Hepion Pharmaceuticals Inc. shares at $0.05
Stetz bought 2,000,000 Hepion Pharmaceuticals Inc. shares at $0.05
Purcell bought 2,000,000 Hepion Pharmaceuticals Inc. shares at $0.05
Appajosyula bought 2,000,000 Hepion Pharmaceuticals Inc. shares at $0.05
Lopriore bought 2,000,000 Hepion Pharmaceuticals Inc. shares at $0.05
Latest Insider Sales
Farajallah sold 14,006 Takeda Pharmaceutical Co Ltd shares at $17.10
Ibrahim sold 7,277 Takeda Pharmaceutical Co Ltd shares at $17.10
Pacheco sold 16,901 Takeda Pharmaceutical Co Ltd shares at $17.10
Duprey sold 47,586 Takeda Pharmaceutical Co Ltd shares at $17.10
Plump sold 165,393 Takeda Pharmaceutical Co Ltd shares at $17.10
Featured Content
Do not Miss































